Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #521 to #570.
- 5-Lipoxygenase activating protein (1 revision)
- ADPRHL2 (1 revision)
- 5-MeO-AET (1 revision)
- AEGIS II Visit Scheduler (test mode) (1 revision)
- 5-MeO-DALT (1 revision)
- 5-MeO-DET (1 revision)
- 5-MeO-DMT (1 revision)
- 5-MeO-DPT (1 revision)
- 5-MeO-MiPT (1 revision)
- 5-MeO-NMT (1 revision)
- 5-MeO-pyr-T (1 revision)
- 5-MeS-DMT (1 revision)
- 5-Methoxy-diisopropyltryptamine (1 revision)
- 5-Methylcytosine (1 revision)
- 5-Methylindole (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
- AARS2 (1 revision)
- ALDH16A1 (1 revision)
- AKR7A3 (1 revision)
- 5-alpha-reductase deficiency case study one (1 revision)
- ACO1 (1 revision)
- ABI1 (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- ACOT1 (1 revision)
- 5-alpha-reductase deficiency electrocardiogram (1 revision)
- ABI gene family member 3 (1 revision)
- 5-alpha-reductase deficiency future or investigational therapies (1 revision)
- ACOT11 (1 revision)
- AIR synthetase (FGAM cyclase) (1 revision)
- AIP (gene) (1 revision)
- AKAP2 (1 revision)
- AKAP (1 revision)
- AKIRIN2 (1 revision)
- ALARA (1 revision)
- AKR1C4 (1 revision)
- ALDH3A1 (1 revision)
- ACOT4 (1 revision)
- AM-087 (1 revision)
- ACOT7 (1 revision)
- ACOT6 (1 revision)
- 5-alpha-reductase deficiency primary prevention (1 revision)
- ALDH1A3 (1 revision)
- ADCC (1 revision)
- 5-alpha-reductase deficiency secondary prevention (1 revision)
- 5-alpha-reductase deficiency surgery (1 revision)
- ALDH1B1 (1 revision)
- ALDH1L1 (1 revision)
- 5-bromouracil (1 revision)
- 5-hydroxytryptophan (1 revision)